TAF1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-TAF1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TAF1 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | unconjugated |
| Size | 0.05 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Polyclonal Antibody to detect TAF1 in human samples. Background: TAF1 is the largest component and core scaffold of the TFIID basal transcription factor complex which also includes TBP. The protein is able to auto phosphorylate or trans phosphorylate other transcription factors such as TP53 on 'Thr-55', leading to MDM2-mediated degradation of TP53, and GTF2A1 and GTF2F1 on Ser residues. TAF1 possesses DNA-binding activity and is essential for progression of the G1 phase of the cell cycle. |
| Immunogen | Immunogen: Polyclonal antibody raised in rabbit against human TAF1 (TATA box binding protein (TBP)-associated factor; Transcription initiation factor TFIID subunit 1), using the recombinant double bromodomain module of the protein. Positive Control: Western blot: HeLa cells |
| Other Names | [TAF (II) 250; TBP-associated factor 250 kDa; p250; BA2R; CCG1; CCGS; TAF2A], [TAF1; TAF1; OF; XDP; BA2R; CCG1; CCGS; DYT3; KAT4; P250; NSCL2; TAF2A; N-TAF1; TAFII250; DYT3/TAF1; TAFII-250; TAF(II)250; BA2R; CCG1; CCGS; TAF2A; p250; TAF(II)250; TAFII-250; TAFII250] |
| Gene, Accession # | [TAF1], Gene ID: 6872, NCBI: NP_001273003.1, UniProt: P21675 |
| Catalog # | MBS841153 |
| Price | $235 |
| Order / More Info | TAF1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies